Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS

被引:33
|
作者
Gungor, Huseyin [1 ]
Ekici, Mehmet [2 ]
Karayigit, Mehmet Onder [3 ]
Turgut, Nergiz Hacer [4 ]
Kara, Haki [1 ]
Arslanbas, Emre [1 ,5 ]
机构
[1] Cumhuriyet Univ, Fac Vet Med, Dept Pharmacol & Toxicol, Sivas 58140, Turkey
[2] Cumhuriyet Univ, Fac Vet Med, Dept Physiol, Sivas 58140, Turkey
[3] Cumhuriyet Univ, Fac Vet Med, Dept Pathol, Sivas 58140, Turkey
[4] Izmir Katip Celebi Univ, Fac Pharm, Dept Pharmacol, Izmir 35620, Turkey
[5] Ataturk Univ, Fac Vet Med, Dept Vet Pharmacol & Toxicol, Erzurum 25240, Turkey
关键词
Zingerone; Pulmonary fibrosis; Antifibrotic effect; Transforming growth factor-beta 1 (TGF-beta 1); Inducible nitric oxide synthase (iNOS); INDUCED LUNG FIBROSIS; NF-KAPPA-B; NITRIC-OXIDE; INJURY; PATHOGENESIS; INHIBITOR; INDUCTION; APOPTOSIS; TOXICITY; GINGER;
D O I
10.1007/s00210-020-01881-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with limited treatment options. Zingerone found in ginger (Zingiber officinale L.) has many pharmacological effects, especially antiinflammatory and antioxidant activity. However, the effect of zingerone on pulmonary fibrosis (PF) is not fully known. The aim of this study was to investigate the effect of zingerone on bleomycin (BLM)-induced PF and its underlying mechanisms. Wistar-albino rats were given single dose of BLM (5 mg/kg, intratracheal) or vehicle (saline). In treatment groups, zingerone (50 and 100 mg/kg, p.o.) was administered orally for 14 days after BLM administration. Rats and lung tissue were weighed to determine lung index. Antioxidant, antiinflammatory effects, and hydroxyproline content of zingerone were determined by ELISA method. Pulmonary inflammation, collagen deposition, and fibrosis score were determined with Hematoxylin-Eosin (HxE) and Masson's trichrome staining. Transforming growth factor-beta 1 (TGF-beta 1) and inducible nitric oxide synthase (iNOS) expressions were detected immunohistochemically. BLM administration increased lipid peroxidation (MDA) and decreased superoxide dismutase (SOD) and glutathione peroxidase (GPx) activity. In addition, BLM caused increased levels of tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) in bronchoalveolar lavage fluid (BALF) and accumulation of collagen bundles. Zingerone administration decreased collagen accumulation, TNF-alpha and IL-1 beta levels, MDA level, TGF-beta 1, and iNOS expression and increased SOD and GPx activity. Histopathological findings supported the results. These results show that zingerone (50 and 100 mg/kg) at both doses significantly contributes to healing of PF by improving inflammation, oxidative stress, and histopathological alterations and by affecting TGF-beta 1 and iNOS signaling pathways.
引用
收藏
页码:1659 / 1670
页数:12
相关论文
共 50 条
  • [41] CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling
    Naoi, H.
    Suzuki, Y.
    Miyagi, A.
    Horiguchi, R.
    Aono, Y.
    Inoue, Y.
    Yasui, H.
    Hozumi, H.
    Karayama, M.
    Furuhashi, K.
    Enomoto, N.
    Fujisawa, T.
    Inui, N.
    Mii, S.
    Ichihara, M.
    Takahashi, M.
    Suda, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [42] Kangfuxin Oral Liquid Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1/Smad Pathway
    Yao, Huan
    Wei, Shujun
    Xiang, Yongjing
    Wu, Ziqiang
    Liu, Weiwei
    Wang, Baojia
    Li, Xueping
    Xu, Huan
    Zhao, Juan
    Gao, Yongxiang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [43] MODULATION OF FIBROBLAST FUNCTION IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS
    CLARK, JG
    MARINO, BA
    KOSTAL, KM
    CLINICAL RESEARCH, 1981, 29 (02): : A444 - A444
  • [44] Hyperbaric Oxygen Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
    Yuan, Yuan
    Li, Yali
    Qiao, Guoqiang
    Zhou, Yilu
    Xu, Zijian
    Hill, Charlotte
    Jiang, Zhenglin
    Wang, Yihua
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [45] Submicron emulsion of cinnamaldehyde ameliorates bleomycin-induced idiopathic pulmonary fibrosis via inhibition of inflammation, oxidative stress and epithelial-mesenchymal transition
    Yan, Li
    Song, Fan
    Li, Hua
    Li, Yao
    Li, Jie
    He, Qiao-Yan
    Zhang, Di
    Wang, Fang
    Zhang, Meng
    Zhao, Hang
    Feng, Tian
    Zhao, Ying-Yong
    Wang, Si-Wang
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 102 : 765 - 771
  • [46] Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis:: a negative feedback loop of TGF-β signaling
    Zhao, Y
    Geverd, DA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 294 (02) : 319 - 323
  • [47] Betaine ameliorates doxorubicin-induced cardiomyopathy by inhibiting oxidative stress, inflammation, and fibrosis through the modulation of AMPK/Nrf2/TGF-β expression
    Singh, Sumeet Kumar
    Yadav, Poonam
    Patel, Dhaneshvaree
    Tanwar, Sampat Singh
    Sherawat, Abhishek
    Khurana, Amit
    Bhatti, Jasvinder Singh
    Navik, Umashanker
    ENVIRONMENTAL TOXICOLOGY, 2024, 39 (08) : 4134 - 4147
  • [48] Sulforaphane attenuates lung fibrosis in bleomycin-induced pulmonary fibrosis via inhibition of TGF-β/Smad signaling
    Kyung, Sun Young
    Kim, You Jin
    Lee, Sang Min
    Kang, Sin Myung
    Lee, Sang Pyo
    Park, Jeong-Woong
    Jeong, Sung Hwan
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [49] Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice
    Shariati, Saeedeh
    Kalantar, Hadi
    Pashmforoosh, Marzieh
    Mansouri, Esrafil
    Khodayar, Mohammad Javad
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
  • [50] Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2
    Chen, Xiang
    Shi, Chaowen
    Meng, Xiannan
    Zhang, Kaijia
    Li, Xiaoyao
    Wang, Cong
    Xiang, Zou
    Hu, Kebin
    Han, Xiaodong
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2016, 101 (01) : 22 - 30